據報華融(02799.HK)與螞蟻討論轉讓螞蟻消費金融公司股權
據外電引述消息人士指,由於監管部分要求逐步退出非核心業務,華融(02799.HK)正計劃轉讓持有的4.99%重慶螞蟻消費金融有限公司股份,目前與螞蟻集團討論,螞蟻集團或會收購價值3.99億元人民幣的股份,並協調其他股東落實對螞蟻消費金融的增資計劃。
華融日前發公告指,計劃採取公開方式於產權交易機構轉讓所持的70%、共6.3億股華融消費金融股份,並擬透過與主要機構債權人協商「債轉股+股權轉讓」方式,對華融信託實施股權重組。
另外,華融計劃更改2015年H股上市時所得資金用途,將剩餘款項約30.03億港元調整爲對重點附屬公司進行資本和資金支持,以提高募集資金使用效率,降低財務成本。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.